CTT Pharmaceutical Holdings, Inc.

Equities

CTTH

US12651E1064

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 20:37:55 28/05/2024 BST			5-day change	1st Jan Change
0.0291 ^USD	+16.40%		+7.78%	+3.93%

2020	CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech	CI
2020	CTT Pharmaceutical Holdings, Inc. Announces Management Appointments	CI

CTT Pharma Signs Agreement for New Oral Products

November 22, 2022 at 11:31 am

(via TheNewswire)

Tampa, Florida, United States - The Newswire - November 22, 2022 - CTT Pharmaceutical Holdings, Inc (OTC:CTTH) has signed a definitive agreement using our technology to make 3 oral products that will include chewing gum, gummies, and pills as prototypes. CTT has also verbally committed to doing additional oral products upon the successful completion of the first 3 products.

CTT will notify shareholders once product development starts and will keep shareholders updated on the progression of these products, which will include testing for stability and efficacy. Ryan Khouri, CEO of CTT Pharma stated, While our dissolvable strips will be the fastest way to deliver APIs, having the ability to create other fast oral products could create more opportunities for CTT.

www.cttpharmaceuticals.com

www.linkedin.com/in/ryan-khouri-679a251b7

CTT Pharma – 813-606-0060

Latest news about CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech	08/09/20	CI
CTT Pharmaceutical Holdings, Inc. Announces Management Appointments	01/09/20	CI
CTT Pharmaceutical Holdings, Inc. Provides Update on the Successful Commercial Introduction of its Sublingual Strips with Aurora Cannabis	23/12/19	CI
CTT Pharmaceutical Holdings, Inc. Announces Management Changes	27/11/19	CI
Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers	08/10/19	CI
Rapid Dose Therapeutics Inc. cancelled the acquisition of certain assets of CTT Pharmaceutical Holdings, Inc..	30/10/18	CI
CTT Pharmaceutical Holdings, Inc. Appoints Jason Dyck to Board of Directors	12/07/18	CI
CTT Pharmaceuticals Announces Executive Management Change	07/06/18	CI
CTT Pharmaceutical Holdings, Inc. announced that it has received $1 million in funding from Aurora Cannabis Inc.	04/06/18	CI
CTT Pharmaceutical Holdings, Inc. announced that it expects to receive $1 million in funding from Aurora Cannabis Inc.	21/05/18	CI
Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical	16/04/18	CI
Rapid Dose Therapeutics Inc. signed a letter of intent to acquire certain assets of CTT Pharmaceutical Holdings, Inc..	16/05/17	CI
CTT Pharmaceutical Holdings and CanniMed Therapeutics Complete Exclusive Canadian Licensing Agreement	17/02/17	CI
CanniMed Ltd. Enters into Letter of Intent with CTT Pharmaceutical Holdings Inc. to License CTT's Orally Dissolvable Thin Film Wafer Technology	23/08/16	CI
CTT Pharmaceutical Holdings, Inc. Announces Resignation of Lucie Letellier as Chief Financial Officer	11/02/16	CI
CTT Pharmaceutical Holdings, Inc. will Change its Ticker to CTTH from MDST.D	25/09/15	CI
Mindesta, Inc. will Change its Name to CTT Pharmaceutical Holdings, Inc	28/08/15	CI
Mindesta Inc. Announces Executive Changes	16/06/15	CI
Mindesta Inc. Auditor Raises 'Going Concern' Doubt	13/04/15	CI
Dr. Stephen Houldsworth, Pharma Manufacturing Expert, Joins CTT Pharmaceuticals Advisory Board	29/01/15	CI
Mindesta, Inc. Announces Executive Changes	01/01/15	CI
CTT Pharmaceuticals Announces Appointment of Michelle Hamilton Page as to the Advisory Board	26/11/14	CI
Mindesta, Inc Appoints Graham Wong to Vice President, Marketing	22/11/14	CI
CTT Pharmaceuticals Appoints Lucie Letellier as CFO	06/11/14	CI
Mindesta Inc. Announces Executive Appointments	01/10/14	CI

Chart CTT Pharmaceutical Holdings, Inc.

Duration

Period

More charts

Company Profile

CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company is specialized in drug delivery systems technology within the pharmaceutical industry. The Company is focused is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company plans to specialize in the development of oral drug delivery systems for pain management and treatment. Film strip encapsulated with the actives to help in pain reduction can include many combinations to help reduce pain and addiction and help patient safely. Oral Thin strips helps in pain management and inflammation indications, such as Arthritis. The Company has invented an ideal intra oral, fast-dissolving drug delivery system. This novel intraoral drug delivery system is its proprietary patented technology and is a thin, flexible and quick-dissolving film.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CTT PHARMACEUTICAL HOLDINGS, INC.	+3.93%	1.28M
MODERNA, INC.	+54.05%	63.85B
IQVIA HOLDINGS INC.	-2.02%	41.83B
LONZA GROUP AG	+40.01%	40.47B
CELLTRION, INC.	-10.22%	27.17B
ICON PUBLIC LIMITED COMPANY	+13.42%	26.52B
ALNYLAM PHARMACEUTICALS, INC.	-21.60%	18.69B
BIO-TECHNE CORPORATION	+2.89%	12.73B
UNITED THERAPEUTICS CORPORATION	+22.40%	12.11B
MEDPACE HOLDINGS, INC.	+27.49%	12.07B

Other Biotechnology & Medical Research